ÂÜÀòÂÒÂ×

Yingbin Ouyang currently serves as the Executive Vice President and Chief Scientific Officer at Cyagen Biosciences, a position held since February 2012. With extensive experience in the field of molecular cellular biology, Yingbin has a proven track record in overseeing the genetically engineered animal model platform, leading R&D efforts, and managing product and service initiatives. Prior roles include Ad Hoc Specialist at AAALAC International, Group Leader in Molecular Biology at Taconic Biosciences, and Scientist at Thios Pharmaceuticals, where significant contributions to drug discovery and biopharmaceuticals were made. Yingbin's academic credentials include a Ph.D. in Molecular Cellular Biology from the Chinese Academy of Medical Sciences and post-doctoral work at Indiana University School of Medicine, along with an M.D. from the Third Military Medical University.